Dermata Therapeutics Inc (DRMA)
1.120
-0.07
(-5.79%)
USD |
NASDAQ |
Nov 15, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Dermata Therapeutics Net Income (Quarterly): -2.829M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -2.829M |
| March 31, 2024 | -3.134M |
| December 31, 2023 | -2.134M |
| September 30, 2023 | -1.719M |
| June 30, 2023 | -1.701M |
| March 31, 2023 | -2.240M |
| December 31, 2022 | -1.670M |
| September 30, 2022 | -2.425M |
| June 30, 2022 | -2.731M |
| Date | Value |
|---|---|
| March 31, 2022 | -2.786M |
| December 31, 2021 | -2.553M |
| September 30, 2021 | -1.713M |
| June 30, 2021 | -1.332M |
| March 31, 2021 | -2.305M |
| December 31, 2020 | -0.3963M |
| September 30, 2020 | -0.5974M |
| June 30, 2020 | -0.8216M |
| March 31, 2020 | -1.421M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-3.134M
Minimum
Mar 2024
-0.3963M
Maximum
Dec 2020
-1.917M
Average
-1.927M
Median
Net Income (Quarterly) Benchmarks
| NeuroBo Pharmaceuticals Inc | -5.652M |
| Cognition Therapeutics Inc | -7.041M |
| ZyVersa Therapeutics Inc | -2.764M |
| Bone Biologics Corp | -0.7837M |
| NovaBay Pharmaceuticals Inc | -1.212M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.884M |
| EPS Diluted (Quarterly) | -4.18 |
| Enterprise Value | -3.473M |
| Earnings Yield | -2.45K% |